SCYNEXIS Inc - SCYX Company Short-Term Debt

Graphic logo of SCYNEXIS, Inc. (SCYX)

The transition to licensing antifungal agents to third-party partners has optimized costs for SCYNEXIS, Inc. (SCYX), ensuring high business margins. Historical short-term debt data demonstrates current liquidity dynamics, where 0.00 forms the current metric value. The triterpenoid ecosystem featuring the drug BREXAFEMME guarantees stability, although geopolitical tensions and sanctions limit the export of medications to isolated regions.

SCYX (scynexis.com) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

SCYNEXIS Inc - analytical breakdowns and key metrics (SCYX)

- price and consensus price forecast:
Price Chart Scynexis|SCYX - Fair Value Consensus
- market capitalization data:
Market Value SCYNEXIS, Inc.|SCYX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share SCYNEXIS|SCYX - Book Capitalization|Market Cap to Net Assets Ratio scynexis.com|SCYX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital SCYNEXIS, Inc.|SCYX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Scynexis|SCYX - Company Aggregate Debt|Debts to Book Capitalization SCYNEXIS, Inc.|SCYX - Long-Term Liabilities|Company Short-Term Debts SCYNEXIS
Analysis of all company metrics:SCYX, scynexis.com
Product sample of Scynexis

Identifying fundamentally resilient assets requires analyzing liquidity via liabilities maturing within one year, which determines a business's ability to service current loans without compromising operational activities. For SCYNEXIS, Inc. (SCYX), this indicator reflects the cost of financing antifungal drug development and royalty management; therefore, analyzing fluctuations in short-term debt allows for an assessment of capital shortage risks during therapy scaling.

Competitors of SCYNEXIS, Inc. (SCYX)

Company Short-Term Debt Summit Therapeutics Inc. (SMMT)|MRNA: Company Short-Term Loans and Borrowings|PCVX (Vaxcyte Corp) - Company Short-Term Debt|Tarsus Corp (TARS) - Company Current Liabilities|CRMD (CorMedix Inc.) - Company Short-Term Debts|Company Short-Term Debts serestherapeutics.com (MCRB)|Spero Therapeutics, Inc. (SPRO) - Company Current Liabilities|Company Short-Term Loans and Borrowings an2therapeutics.com (ANTX)|Company Short-Term Debts PYPD|YS Biopharma Co., Ltd. - Short-Term Debt Volume|Iterum Therapeutics, plc (ITRM) - Company Short-Term Debt|PHGE - Company Short-Term Indebtedness|Company Short-Term Debts soligenix.com (SNGX)|60 Degrees Pharmaceuticals, Inc. (SXTP) - Current Liabilities|Company Short-Term Debts OGEN (Oragenics, Inc.)|Short-Term Debt Onconetix Corporation|Company Short-Term Debts OPGN (OpGen, Inc.)